Chaitra S. Ujjani, MD
At the age of 17, I knew that I was going to be a doctor. I have never once regretted that decision. As an oncologist, I find it satisfying to work with patients to achieve a common goal. The science behind different forms of cancer is also fascinating — I want to know what’s driving them. There’s a creativity to oncology right now, in trying to figure out how to bring new therapies together and how to integrate them with current treatment approaches. I’m invested in trying to understand that so I can improve outcomes for you. It’s this excitement that brings me to work every day.
Oncology is an art in the sense that I can’t just look at the data and make a decision about what’s best for you. There are many nuances to consider, not only the biology of your disease but also you as the patient: your personal goals, your living situation, your fitness level and your age, just to name a few. When it comes to blood cancers, there are so many more treatment combinations available than there used to be, which is great, but it also means that the way forward isn’t simple. Together, we take in all of the information and decide on the best approach.
Specialties and clinical expertise: Hematologic malignancies
I am a board-certified medical oncologist who specializes in the treatment of lymphomas and chronic lymphocytic leukemia (CLL). These cancers affect white blood cells, which are responsible for fighting off infection. For more than a decade, I’ve designed and led multi-center clinical trials that test new drug combinations for treating these diseases, with the goals of more precisely targeting cancer while decreasing the intensity of side effects. I’m also interested in immunotherapy, how patients’ own immune cells can be extracted and engineered to attack their cancer. In addition to patient care and research, I am an active member of the Leukemia & Lymphoma Society, and I’ve presented my research at the annual conference of the American Society of Hematology.
Dr. Ujjani received the 2016 American Cancer Society Young Investigator Research Grant to support her clinical trial work testing new drug combinations in the treatment of relapsed follicular lymphoma.
This award honors excellence in patient education and research.
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.
SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.
SCCA's Chaitra Ujjani, MD, talked about the importance of cancer patients receiving the COVID-19 vaccine.
SCCA's Chaitra S. Ujjani, MD, spoke with CNN Health about COVID-19 vaccinations for patients with blood cancers and discussed how SCCA is conducting clinical trials for other cancer types including certain immune system and blood cancers
Your care team
SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.